Ovarian
Biomarker discovery and PARP inhibitors have opened new frontiers in treatment. Efforts in early detection through genetic screening are showing promising results.
FDA sets priority review date for Verastem Oncology’s new ovarian cancer drug – Boston Business Journal
The FDA is aiming to make a decision about the treatment before the end of June.
Latest Ovarian Cancer Screening and Treatment Breakthroughs
Learn how the latest advancements may lead to earlier diagnosis and help prolong the lives of women with ovarian cancer.
Eating egg linked to higher breast, ovary and prostate cancer risks, study finds
A recent study from Harvard University has identified a potential connection between eating eggs and the risk of developing certain types of cancer, particularly breast, ovarian, and fatal prostate cancer. The findings, published in the British Journal of Nutrition, shed light on the role egg consumption might play in the development of cancers related to sex […]
AI detects ovarian cancer better than human doctors: Study
AI based models achieved an accuracy rate of 86% for detecting ovarian cancer, compared to 82% for human experts.
